Consult
Log In
Menu
Consult
Log in

by Josh Forsythe, on March 24, 2015

ST LOUIS, MO –  PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians prioritized, actionable and deeply informed data for a quicker diagnosis. PierianDx also announced the addition of clinical trials, FDA drug labels, and treatment guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology to its industry-leading knowledgebase.

Read Story
Topics:News